Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 180 posts found.

novo_nordisk

Novo Nordisk says Tresiba reduces hypoglycaemia risk vs Lantus

February 23, 2016
Manufacturing and Production, Research and Development Novo Nordisk

Novo Nordisk has announced trial results suggesting that its drug Tresiba (insulin degludec) carries a reduced risk of hypoglycaemia episodes, …

News
Novolog pen

Novo Nordisk files for new insulin approval

December 10, 2015
Manufacturing and Production, Research and Development, Sales and Marketing FDA, NDA, Novo Nordisk, NovoLog, diabetes, insulin aspart, new drug application

Novo Nordisk has submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. If successful, the Danish …

News
Logos

New regulatory submissions for AbbVie and Novo Nordisk

December 4, 2015
Medical Communications AbbVie, EMA, FDA, Novo Nordisk, Viekira Pak, insulin aspart

AbbVie and Novo Nordisk have submitted new drug applications to the US FDA and European Medicines Agency (EMA) respectively. The …

News
Victoza

Novo Nordisk buys Xoma diabetes program and scores trial successes

December 2, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …

News
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015
Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

News

Jardiance scores more cardiovascular outcomes data

November 10, 2015
Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …

News
Novo Nordisk building

Novo Nordisk invests in new insulin-filling facility

November 4, 2015
Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production

Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …

News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

News
novo_nordisk

Novo Nordisk posts strong nine-month results

October 29, 2015
Sales and Marketing Novo Nordisk, insulin

Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …

News
lars-rebien-soerensen

Novo chief executive ranked ‘world’s best’

October 14, 2015
Medical Communications, Sales and Marketing Harvard Business Review, Lars Rebien Sorensen, Novo Nordisk

Novo Nordisk chief executive Lars Rebien Sørensen has been named the best-performing in the world by the Harvard Business Review. …

Appointment
diabetes_uk_logo

Novo Nordisk and Diabetes UK extend ‘Clinical Champions’ initiative

October 6, 2015
Medical Communications Novo Nordisk, diabetes

Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …

News
stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015
Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …

Appointment
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …

News
nn_flag

Novo Nordisk to build manufacturing plant for FlexPen in Iran

September 22, 2015
Manufacturing and Production Iran, Novo Nordisk, diabetes

Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …

News
Klaus Henning Jensen

Working Life: Novo Nordisk’s Klaus Henning-Jensen

September 21, 2015
Sales and Marketing Novo Nordisk, Working Life

How did you find your way into your current role?I started out in medicine at Bispebjerg, which is a large …

Feature

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024